AlphaYouDJ
Insider selling
Daniel Joseph Apel sold $934K of Arrowhead Pharmaceuticals, Inc. (ARWR) stock
Daniel Joseph Apel, Chief Financial Officer of Arrowhead Pharmaceuticals, Inc. (ARWR), sold 13,095 shares of ARWR stock worth $934K, per an SEC Form 4 filed Apr 24, 2026.
It was an open-market sale.
The trade happened on Apr 22, 2026, 2 days before it was made public.
ARWR has moved -6.9% since the trade date, from $73.92 to $68.79 (Sep 21, 2026 close).
- Traded
- Apr 22, 2026
- Disclosed
- Apr 24, 2026
- Filing delay
- 2 days
- Price since
- -6.9%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More ARWR insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.